Market Overview

Benzinga's Volume Movers

Related CNAT
Conatus Pharmaceuticals Announces Selection of Late-Breaking Oral Presentation as Noteworthy Abstract to be Highlighted in AASLD President's Press Conference at AASLD Annual Meeting
Conatus Pharmaceuticals Announces Acceptance of Abstracts for AASLD Annual Meeting
Solithromycin From Cempra Is Positioning To Be The Treatment Of Choice For CABP (Seeking Alpha)
Related GALT
Morning Market Losers
Galectin Therapeutics' Executive Chairman to Discuss Silent Epidemic and Company's Role in Developing Treatments for NASH and Other Diseases at Robins Equity Research Roundup Conference

Conatus Pharmaceuticals (NASDAQ: CNAT) shares moved up 35.20% to $13.25 after jumping 57.05% on Thursday. The volume of Conatus Pharmaceuticals shares traded was 6786% higher than normal.

Galectin Therapeutics (NASDAQ: GALT) shares rose 21.19% to $16.35. The volume of Galectin Therapeutics shares traded was 3091% higher than normal. Galectin reported that it has sold 2.39 million shares at an average price of $9.99 per share.

Intercept Pharmaceuticals (NASDAQ: ICPT) shares climbed 41.73% to $391.00. The volume of Intercept Pharmaceuticals shares traded was 2251% higher than normal. Citigroup lifted the price target on the stock from $60.00 to $400.00, while Bank of America raised the price target from $81.00 to $872.00.

American Pacific (NASDAQ: APFC) surged 18.97% to $46.54. The volume of American Pacific shares traded was 1202% higher than normal. American Pacific agreed to be acquired by H.I.G. Capital LLC.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (APFC + CNAT)

Get Benzinga's Newsletters